Cargando…
Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead
While immune checkpoint inhibitors (ICIs) have ushered in major changes in standards of care for many solid tumor malignancies, primary and acquired resistance is common. Insufficient antitumor T cells, inadequate function of these cells, and impaired formation of memory T cells all contribute to re...
Autores principales: | Kirtane, Kedar, Elmariah, Hany, Chung, Christine H, Abate-Daga, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311333/ https://www.ncbi.nlm.nih.gov/pubmed/34301811 http://dx.doi.org/10.1136/jitc-2021-002723 |
Ejemplares similares
-
The State of Cellular Adoptive Immunotherapy for Neuroblastoma and Other Pediatric Solid Tumors
por: Le, Thanh-Phuong, et al.
Publicado: (2017) -
Challenges ahead
por: Muglia, Valdair F
Publicado: (2023) -
Promises and challenges of adoptive T-cell therapies for solid tumours
por: Morotti, Matteo, et al.
Publicado: (2021) -
Targeting RAD51-Mediated Homologous Recombination as a Treatment for Advanced Solid and Hematologic Malignancies: Opportunities and Challenges Ahead
por: Tsang, Erica S, et al.
Publicado: (2022) -
Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies
por: Belli, Carmen, et al.
Publicado: (2022)